VLADIMIR PUTIN
ARCHIVE OF THE OFFICIAL SITE
OF THE 2008-2012 PRIME MINISTER
OF THE RUSSIAN FEDERATION
VLADIMIR PUTIN
ARCHIVE OF THE OFFICIAL SITE
OF THE 2008-2012 PRIME MINISTER
OF THE RUSSIAN FEDERATION
VLADIMIR PUTIN
“Support from Russian citizens has always helped us, and I’m confident that the government’s future line-up will rely on the people. We must never forget about the needs of ordinary people. We must always remember how government-level decisions influence the lives of all ordinary Russian citizens.”
"The 2012 APEC forum is also a good opportunity to concentrate our resources, solve the many problems of our largest metropolis in the Far East and make the city's residents' lives more comfortable. We can position Vladivostok as Russia's "gateway to the Pacific" and a promising venue for international cooperation."
"The fulfilment of all these plans will enable us to hold an important event - the 2012 APEC forum. This upcoming summit is a significant political and economic event for the entire Asia-Pacific region. Certainly, a successful event will enable Russia to enhance its international standing and will help in making additional contacts with our partners in the region."
"Disintegration is one of the reasons why the Russian pharmaceutical industry lags behind. We must consolidate. The industry needs integrated structures linking research and development with manufacture. These would of course make use of market instruments."
"It is taking Russian manufacturers too long to switch to GMP and other international standards, without which the Russian pharmaceutical industry will never become an equal competitor in the world."
"We should provide for the greatest possible number of medicines to be manufactured in Russia-in particular, through licensed production and generics."
"There is a third challenge-preventing the sale of counterfeit medicines and medicines that have already expired. These medicines threaten people's health and even lives, and our efforts to combat them should not subside."
"The tasks that the state and the pharmaceutical companies face are clear. First, the policy for the state to purchase medicines needs to be overhauled to introduce clear-cut, transparent market rules to eliminate the possibility of loopholes and abuses, which allow sidestepping the terms of a public auction. When public auctions are aboveboard, prices fall significantly."
"Russian-manufactured medicines purchased using government money must make up no less than a half of the total supply, in terms of value, within the next two or three years. We should shift to long-term contracts with Russian manufacturers to supply medicines to government, municipal and corporate hospitals and clinics, as well as to medical centres affiliated with the Academy of Medical Sciences."
"Guaranteed purchases of medicine is one of the principal financial approaches for implementing state strategy in this field. In particular, government and other centralised companies must make such purchases, whose amount is quite sufficient in our country, approaching 230 billion roubles a year. However, Russian manufacturers have no permanent, or at least long-term, access to the market-suffice to say that federal programmes account for fewer than 10% of the volume of all Russian-made medicines sold."
